Business Context and Reporting Period
TransDigm Group Incorporated (NYSE: TDG) filed a Form 8-K on November 8, 2011, to disclose a material event under Regulation FD. The company operates in the aerospace sector, manufacturing proprietary components for commercial aircraft.
Key Financial Metrics
This filing does not report periodic financial results such as revenue, profit, cash flow, or margins. The primary financial metric disclosed is the transaction value of a new acquisition:
- Acquisition Price: Approximately $84 million in cash.
- Target Company: Harco Laboratories, Incorporated.
Material Changes
The material change reported is the entry into a definitive agreement to acquire Harco Laboratories, a manufacturer of highly engineered components for major commercial aircraft located in Branford, Connecticut. This represents a strategic expansion of TransDigm's product portfolio.
Outlook, Risks, and Contingencies
Closing Conditions: The transaction is subject to review under the Hart-Scott-Rodino Act and other customary closing conditions.
Timing: The acquisition is expected to close in the first quarter of fiscal 2012.
Unusual Items: None reported beyond the standard acquisition announcement.
Investor Verification Checklist
- Confirm the final closing date of the Harco Laboratories acquisition in Q1 fiscal 2012.
- Verify the final purchase price and any adjustments to the $84 million cash consideration.
- Monitor regulatory approvals under the Hart-Scott-Rodino Act.
- Review the attached press release (Exhibit 99.1) for specific details on Harco's product lines and integration plans.